相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Age-Dependent Human Hepatic Carboxylesterase 1 (CES1) and Carboxylesterase 2 (CES2) Postnatal Ontogeny
Ronald N. Hines et al.
DRUG METABOLISM AND DISPOSITION (2016)
Acetaminophen: Dose-Dependent Drug Hepatotoxicity and Acute Liver Failure in Patients
Hartmut Jaeschke
DIGESTIVE DISEASES (2015)
Genetic variation, expression and ontogeny of sulfotransferase SULT2A1 in humans
L. Ekstrom et al.
PHARMACOGENOMICS JOURNAL (2015)
Phase 0 and phase III transport in various organs: Combined concept of phases in xenobiotic transport and metabolism
Barbara Doering et al.
DRUG METABOLISM REVIEWS (2014)
A human life-stage physiologically based pharmacokinetic and pharmacodynamic model for chlorpyrifos: Development and validation
Jordan Ned Smith et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2014)
Identifying important life stages for monitoring and assessing risks from exposures to environmental contaminants: Results of a World Health Organization review
Elaine A. Cohen Hubal et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2014)
Pharmacogenomics of acetaminophen in pediatric populations: a moving target
Anne E. Krasniak et al.
FRONTIERS IN GENETICS (2014)
Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk
Silvia Selinski et al.
ARCHIVES OF TOXICOLOGY (2013)
Metabolic Activation of Polycyclic Aromatic Hydrocarbons and Aryl and Heterocyclic Amines by Human Cytochromes P450 2A13 and 2A6
Tsutomu Shimada et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2013)
Heterocyclic amine intake, smoking, cytochrome P450 1A2 and N-acetylation phenotypes, and risk of colorectal adenoma in a multiethnic population
Jenna Voutsinas et al.
GUT (2013)
Establishment of Metabolism and Transport Pathways in the Rodent and Human Fetal Liver
Jamie E. Moscovitz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Developmental expression of drug metabolizing enzymes: Impact on disposition in neonates and young children
R. N. Hines
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Age Related Changes in Fractional Elimination Pathways for Drugs: Assessing the Impact of Variable Ontogeny on Metabolic Drug-Drug Interactions
Farzaneh Salem et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2013)
A sensitive and specific CYP cocktail assay for the simultaneous assessment of human cytochrome P450 activities in primary cultures of human hepatocytes using LC-MS/MS
Venkateswaran C. Pillai et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2013)
Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species
Bridgette D. Semple et al.
PROGRESS IN NEUROBIOLOGY (2013)
Metabolic changes and DNA hypomethylation in cerebellum are associated with behavioral alterations in mice exposed to trichloroethylene postnatally
Sarah J. Blossom et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Prediction of dose-hepatotoxic response in humans based on toxicokinetic/toxicodynamic modeling with or without in vivo data: A case study with acetaminophen
Alexandre R. R. Pery et al.
TOXICOLOGY LETTERS (2013)
RNA-Sequencing Quantification of Hepatic Ontogeny and Tissue Distribution of mRNAs of Phase II Enzymes in Mice
Hong Lu et al.
DRUG METABOLISM AND DISPOSITION (2013)
Ontogeny of mammalian metabolizing enzymes in humans and animals used in toxicological studies
Shakil Ahmed Saghir et al.
CRITICAL REVIEWS IN TOXICOLOGY (2012)
Ontogeny of Hepatic Glucuronidation; Methods and Results
Elke H.J. Krekels et al.
CURRENT DRUG METABOLISM (2012)
Omeprazole limited sampling strategies to predict area under the concentration-time curve ratios: implications for cytochrome P450 2C19 and 3A phenotyping
Eileen B. Lawson et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Lack of toxicity after paracetamol overdose in a extremely preterm neonate
Roser Porta et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Differential mRNA expression of neuroimmune markers in the hippocampus of infant mice following toluene exposure during brain developmental period
Tin-Tin Win-Shwe et al.
JOURNAL OF APPLIED TOXICOLOGY (2012)
Postnatal exposure to trichloroethylene alters glutathione redox homeostasis, methylation potential, and neurotrophin expression in the mouse hippocampus
Sarah J. Blossom et al.
NEUROTOXICOLOGY (2012)
Ontogeny of Novel Cytochrome P450 Gene Isoforms during Postnatal Liver Maturation in Mice
Julia Yue Cui et al.
DRUG METABOLISM AND DISPOSITION (2012)
Human Glutathione Transferases Catalyzing the Conjugation of the Hepatoxin Microcystin-LR
Franca M. Buratti et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
In Vitro Age-Dependent Enzymatic Metabolism of Chlorpyrifos and Chlorpyrifos-Oxon in Human Hepatic Microsomes and Chlorpyrifos-Oxon in Plasma
Jordan Ned Smith et al.
DRUG METABOLISM AND DISPOSITION (2011)
Does early-life exposure to organophosphate insecticides lead to prediabetes and obesity?
Theodore A. Slotkin
REPRODUCTIVE TOXICOLOGY (2011)
Organophosphate exposure during a critical developmental stage reprograms adenylyl cyclase signaling in PC12 cells
Abayomi A. Adigun et al.
BRAIN RESEARCH (2010)
Changes in the Gene Expression and Enzyme Activity of Hepatic Cytochrome P450 in Juvenile Sprague-Dawley Rats
Yoshiji Asaoka et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2010)
Human hepatic CYP2B6 developmental expression: The impact of age and genotype
Edward L. Croom et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Human carboxylesterases HCE1 and HCE2: Ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin
Dongfang Yang et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Prenatal chlorpyrifos exposure alters motor behavior and ultrasonic vocalization in cd-1 mouse pups
Aldina Venerosi et al.
ENVIRONMENTAL HEALTH (2009)
Developmental Changes in PON1 Enzyme Activity in Young Children and Effects of PON1 Polymorphisms
Karen Huen et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2009)
GENETIC POLYMORPHISM IN PARAOXONASE 1 (PON1): POPULATION DISTRIBUTION OF PON1 ACTIVITY
Gary Ginsberg et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS (2009)
THE INFLUENCE OF GENETIC POLYMORPHISMS ON POPULATION VARIABILITY IN SIX XENOBIOTIC-METABOLIZING ENZYMES
Gary Ginsberg et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS (2009)
GENETIC POLYMORPHISM IN N-ACETYLTRANSFERASE (NAT): POPULATION DISTRIBUTION OF NAT1 AND NAT2 ACTIVITY
Katy Walker et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS (2009)
Ontogeny of glutathione and glutathione-related antioxidant enzymes in rat liver
Fawzy Elbarbry et al.
RESEARCH IN VETERINARY SCIENCE (2009)
4-Aminobiphenyl Downregulation of NAT2 Acetylator Genotype-Dependent N- and O-acetylation of Aromatic and Heterocyclic Amine Carcinogens in Primary Mammary Epithelial Cell Cultures from Rapid and Slow Acetylator Rats
Felicia A. Jefferson et al.
TOXICOLOGICAL SCIENCES (2009)
Characterizing uncertainty and population variability in the toxicokinetics of trichloroethylene and metabolites in mice, rats, and humans using an updated database, physiologically based pharmacokinetic (PBPK) model, and Bayesian approach
Weihsueh A. Chiu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)
Acute hepatic failure in an infant caused by acetaminophen (paracetamol) toxicity
K. Ebenezer et al.
ANNALS OF TROPICAL PAEDIATRICS (2008)
Meat intake, heterocyclic amine exposure, and metabolizing enzyme polymorphisms in relation to colorectal polyp risk
Aesun Shin et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Acetaminophen-Associated Hepatic Injury: Evaluation of Acetaminophen Protein Adducts in Children and Adolescents With Acetaminophen Overdose
L. P. James et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
The ontogeny of drug metabolizing enzymes and transporters in the rat
Loeckie de Zwart et al.
REPRODUCTIVE TOXICOLOGY (2008)
Evaluation of the assumptions of an ontogeny model of rat hepatic cytochrome p450 activity
Jane Alcorn et al.
DRUG METABOLISM AND DISPOSITION (2007)
An age-dependent physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus insecticide chlorpyrifos in the preweanling rat
Charles Timchalk et al.
TOXICOLOGICAL SCIENCES (2007)
Drug metabolism in the paediatric population and in the elderly
Margherita Strolin Benedetti et al.
DRUG DISCOVERY TODAY (2007)
Predicting age-appropriate pharmacokinetics of six volatile organic compounds in the rat utilizing physiologically based pharmacokinetic modeling
Chester E. Rodriguez et al.
TOXICOLOGICAL SCIENCES (2007)
Modulation of hepatic and renal metabolism and toxicity of trichloroethylene and perchloroethylene by alterations in status of cytochrome P450 and glutathione
Lawrence H. Lash et al.
TOXICOLOGY (2007)
Acetaminophen-induced hepatic failure with encephalopathy in a newborn
L. Walls et al.
JOURNAL OF PERINATOLOGY (2007)
Age-dependent partition coefficients for a mixture of volatile organic solvents in Sprague-Dawley rats and humans
Deirdre A. Mahle et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2007)
Foetal and adult human CYP3A isoforms in the bioactivation of organophosphorothionate insecticides
Franca M. Buratti et al.
TOXICOLOGY LETTERS (2006)
Epirubicin glucuronidation and UGT2B7 developmental expression
Matthew J. Zaya et al.
DRUG METABOLISM AND DISPOSITION (2006)
Comparative metabolism and disposition of trichloroethylene in Cyp2e1-/- and wild-type mice
Dojung Kim et al.
DRUG METABOLISM AND DISPOSITION (2006)
Development of physiologically based toxicokinetic models for improving the human indoor exposure assessment to water contaminants: Trichloroethylene and trihalomethanes
Sami Haddad et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2006)
Bayesian population analysis of a harmonized physiologically based pharmacokinetic model of trichloroethylene and its metabolites
C. Eric Hack et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2006)
Effect of prenatal exposure of deltamethrin on the ontogeny of xenobiotic metabolizing cytochrome P450s in the brain and liver of offsprings
Ashu Johri et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2006)
Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: A case study with toluene
A. Nong et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2006)
Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver
ZB Duanmu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Developmental expression of aldehyde dehydrogenase in rat: a comparison of liver and lung development
M Yoon et al.
TOXICOLOGICAL SCIENCES (2006)
Pulmonary bioactivation of trichloroethylene to chloral hydrate: Relative contributions of CYP2E1, CYP2F, and CYP2B1
PG Forkert et al.
DRUG METABOLISM AND DISPOSITION (2005)
Comparative carboxylesterase activities in infant and adult liver and their in vitro sensitivity to chlorpyrifos oxon
CN Pope et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2005)
Toward cost-benefit analysis of acute behavioral effects of toluene in humans
VA Benignus et al.
RISK ANALYSIS (2005)
Neonatal toluene exposure alters N-methyl-D-aspartate receptor subunit expression in the hippocampus and cerebellum in juvenile rats
YF Lee et al.
NEUROPHARMACOLOGY (2005)
Assessing susceptibility from early-life exposure to carcinogens
HA Barton et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2005)
Developmental expression of human hepatic CYP2C9 and CYP2C19
SB Koukouritaki et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: Implications for assessing children's risks from environmental agents
G Ginsberg et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2004)
Age-related differences in susceptibility to carcinogenesis: A quantitative analysis of empirical animal bioassay data
D Hattis et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2004)
Incorporating pharmacokinetic differences between children and adults in assessing children's risks to environmental toxicants
G Ginsberg et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry
HJ Clewell et al.
TOXICOLOGICAL SCIENCES (2004)
Biotransformation of chlorpyrifos and diazinon by human liver microsomes and recombinant human cytochrome P450s (CYP)
C Sams et al.
XENOBIOTICA (2004)
Serotonergic systems targeted by developmental exposure to chlorpyrifos: Effects during different critical periods
JE Aldridge et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2003)
Human hepatic CYP2E1 expression during development
EK Johnsrud et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Paracetamol and metabolite pharmacokinetics in infants
CD van der Marel et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Neonatal ontogeny of murine arylamine N-acetyltransferases:: Implications for arylamine genotoxicity
CA McQueen et al.
TOXICOLOGICAL SCIENCES (2003)
Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues
D Choudhary et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2003)
Differences in pharmacokinetics between children and Adults - II. Children's variability in drug elimination half-lives and in some parameters needed for physiologically-based pharmacokinetic modeling
D Hattis et al.
RISK ANALYSIS (2003)
Developmental expression of the major human hepatic CYP3A enzymes
JC Stevens et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
The impact of cytochrome P450 2E1-dependent metabolic variance on a risk-relevant pharmacokinetic outcome in humans
JC Lipscomb et al.
RISK ANALYSIS (2003)
Population distribution of aldehyde dehydrogenase-2 genetic polymorphism: Implications for risk assessment
G Ginsberg et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2002)
Kinetic parameters of OPT pesticide desulfuration by c-DNA expressed human CYPs
FM Buratti et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2002)
The use of in vitro metabolic parameters and physiologically based pharmacokinetic (PBPK) modeling to explore the risk assessment of trichloroethylene
EM Hissink et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2002)
The ontogeny of human drug-metabolizing enzymes: Phase II conjugation enzymes and regulatory mechanisms
DG McCarver et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
The ontogeny of human drug-metabolizing enzymes: Phase I oxidative enzymes
RN Hines et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Ontogeny of hepatic and renal systemic clearance pathways in infants - Part I
J Alcorn et al.
CLINICAL PHARMACOKINETICS (2002)
Ontogeny of hepatic and renal systemic clearance pathways in infants - Part II
J Alcorn et al.
CLINICAL PHARMACOKINETICS (2002)
Cytochrome P-450 mRNA expression in human liver and its relationship with enzyme activity
C Rodríguez-Antona et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2001)
Pediatric acetaminophen overdose
G Isbister et al.
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY (2001)
DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in fetal tissues of patas monkeys after transplacental exposure
S Josyula et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2000)
Comparative cholinergic neurotoxicity of oral chlorpyrifos exposures in preweanling and adult rats
Q Zheng et al.
TOXICOLOGICAL SCIENCES (2000)
Metabolism of trichloroethylene
LH Lash et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2000)
Metabolism and toxicity of trichloroethylene and S-(1,2-dichlorovinyl)-L-cysteine in freshly isolated human proximal tubular cells
BS Cummings et al.
TOXICOLOGICAL SCIENCES (2000)
Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation
PT Manyike et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)